How Private Equity Is Buying Up Veterinary Specialty Hospitals

Lucas and Luna examine the quiet wave of private equity consolidation in veterinary specialty and emergency care. While general practice pet care has seen roll-ups for years, the target has shifted to high-revenue referral hospitals offering oncology, neurology, and surgery. Lucas breaks down the economics: a single specialty hospital can generate three to eight million dollars in annual EBITDA, and private equity firms are paying eight to twelve times that figure. He explains why these practices are attractive — sticky referral networks, high barriers to entry, and pricing power that general practices lack. Luna questions whether consolidation is driving up pet owner costs, and Lucas shares data showing that emergency visit bills at PE-backed hospitals are running twenty to forty percent higher than independent counterparts. They discuss the role of veterinary shortages, the rise of corporate-owned networks like BluePearl and Ethos Veterinary Health, and the tension between clinical autonomy and financial engineering. The episode ends with a question: will this wave end with a few dominant players, or will it face regulatory pushback? #PrivateEquity #VeterinaryCare #SpecialtyHospitals #PetCare #RollUps #BluePearl #EthosVeterinaryHealth #EBITDA #Consolidation #BusinessAcquisitions #EmergencyVet #PetOwners #VetShortage #ClinicalAutonomy #MarsPetcare #DealRoom #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo